Preoperative management of anticoagulation and antiplatelet agents.
This article describes current literature and treatment plans for managing anticoagulation and antiplatelet agents in patients presenting with hip fractures. Indications for anticoagulation and antiplatelet agents are discussed, and management techniques for when patients present with hip fractures are reviewed.
Department of Internal Medicine, Beth Israel Deaconess Medical Center, LMOB 1B, 110 Francis Street, Boston, MA 02215, USA. Electronic address: lgleason@bidmc.harvard.edu.
Lauren Jan
LJ
Gleason
Department of Medicine, Highland Hospital, 1000 South Avenue, Box 58, Rochester, NY 14620, USA.
Susan M
SM
Friedman
D000368:Aged; D000369:Aged, 80 and over; D000925:Anticoagulants / Q000008:administration & dosage*; D015897:Comorbidity; D016330:Frail Elderly; D015577:Geriatric Assessment / Q000379:methods; D006470:Hemorrhage / Q000517:prevention & control*; D006620:Hip Fractures / Q000601:surgery*; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage*; D011183:Postoperative Complications / Q000517:prevention & control*; D011300:Preoperative Care; D018570:Risk Assessment / Q000379:methods
D000925:Anticoagulants; D010975:Platelet Aggregation Inhibitors
Anticoagulation; Antiplatelet; Aspirin; Clopidogrel; Warfarin